Advances in the treatment of relapsing—remitting multiple sclerosis — critical appraisal of fingolimod

Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system, traditionally considered to be an autoimmune, demyelinating disease. Based on this understanding, initial therapeutic strategies were directed at immune modulation and inflammation control. At present, there ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasperini, Claudio, Ruggieri, Serena, Mancinelli, Chiara Rosa, Pozzilli, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590932/
https://www.ncbi.nlm.nih.gov/pubmed/23483794
http://dx.doi.org/10.2147/TCRM.S17426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590932/
https://www.ncbi.nlm.nih.gov/pubmed/23483794
http://dx.doi.org/10.2147/TCRM.S17426

Ejemplares similares